Credit Suisse’s Surgery Partners SGRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $3.15M | Buy |
105,581
+1,410
| +1% | +$42.1K | ﹤0.01% | 1568 |
|
|
2023
Q4 | $3.33M | Buy |
104,171
+7,951
| +8% | +$254K | ﹤0.01% | 1571 |
|
|
2023
Q3 | $2.81M | Sell |
96,220
-1,909
| -2% | -$55.8K | ﹤0.01% | 1614 |
|
|
2023
Q2 | $4.41M | Buy |
98,129
+10,964
| +13% | +$493K | ﹤0.01% | 1409 |
|
|
2023
Q1 | $3M | Buy |
87,165
+11,447
| +15% | +$395K | ﹤0.01% | 1622 |
|
|
2022
Q4 | $2.11M | Buy |
75,718
+35,420
| +88% | +$987K | ﹤0.01% | 1824 |
|
|
2022
Q3 | $943K | Buy |
40,298
+6,129
| +18% | +$143K | ﹤0.01% | 2356 |
|
|
2022
Q2 | $988K | Buy |
34,169
+5,248
| +18% | +$152K | ﹤0.01% | 2382 |
|
|
2022
Q1 | $1.59M | Buy |
28,921
+6,053
| +26% | +$333K | ﹤0.01% | 2218 |
|
|
2021
Q4 | $1.22M | Sell |
22,868
-7,751
| -25% | -$414K | ﹤0.01% | 2454 |
|
|
2021
Q3 | $1.3M | Buy |
30,619
+6,603
| +27% | +$280K | ﹤0.01% | 2411 |
|
|
2021
Q2 | $1.6M | Buy |
24,016
+2,048
| +9% | +$136K | ﹤0.01% | 2327 |
|
|
2021
Q1 | $973K | Sell |
21,968
-118
| -0.5% | -$5.23K | ﹤0.01% | 2597 |
|
|
2020
Q4 | $642K | Buy |
22,086
+4,451
| +25% | +$129K | ﹤0.01% | 2846 |
|
|
2020
Q3 | $386K | Buy |
17,635
+5,384
| +44% | +$118K | ﹤0.01% | 2798 |
|
|
2020
Q2 | $141K | Buy |
+12,251
| New | +$141K | ﹤0.01% | 3157 |
|
|
2020
Q1 | – | Sell |
-33,388
| Closed | -$522K | – | 3486 |
|
|
2019
Q4 | $522K | Sell |
33,388
-5,373
| -14% | -$84K | ﹤0.01% | 2892 |
|
|
2019
Q3 | $287K | Sell |
38,761
-61,557
| -61% | -$456K | ﹤0.01% | 3058 |
|
|
2019
Q2 | $817K | Buy |
100,318
+89,789
| +853% | +$731K | ﹤0.01% | 2484 |
|
|
2019
Q1 | $118K | Buy |
+10,529
| New | +$118K | ﹤0.01% | 3242 |
|
|
2018
Q3 | – | Sell |
-13,680
| Closed | -$204K | – | 3401 |
|
|
2018
Q2 | $204K | Sell |
13,680
-1,003
| -7% | -$15K | ﹤0.01% | 3297 |
|
|
2018
Q1 | $251K | Sell |
14,683
-620
| -4% | -$10.6K | ﹤0.01% | 3210 |
|
|
2017
Q4 | $185K | Sell |
15,303
-7,476
| -33% | -$90.4K | ﹤0.01% | 3264 |
|
|
2017
Q3 | $235K | Buy |
22,779
+12,584
| +123% | +$130K | ﹤0.01% | 3370 |
|
|
2017
Q2 | $232K | Sell |
10,195
-4,888
| -32% | -$111K | ﹤0.01% | 3190 |
|
|
2017
Q1 | $294K | Sell |
15,083
-37,158
| -71% | -$724K | ﹤0.01% | 3147 |
|
|
2016
Q4 | $828K | Buy |
52,241
+26,217
| +101% | +$416K | ﹤0.01% | 2815 |
|
|
2016
Q3 | $527K | Sell |
26,024
-20,341
| -44% | -$412K | ﹤0.01% | 3062 |
|
|
2016
Q2 | $830K | Buy |
46,365
+36,351
| +363% | +$651K | ﹤0.01% | 2794 |
|
|
2016
Q1 | $133K | Buy |
+10,014
| New | +$133K | ﹤0.01% | 3477 |
|